Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00611078 · ClinicalTrials.gov registry record
Environmental Pollutants and the Risk of Soft Tissue Sarcoma: A Pilot Study
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 56
- Enrollment target
NCT00611078: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00611078 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 56 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00611078 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 56 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the feasibility of conducting a large hospital based case control study of the role of dioxins and dioxinlike polychlorinated dibenzofurans (PCDFs) and polychlorinated biphenyls (PCBs).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2004-09 |
| Est. Completion | 2011-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00611078
The ClinicalTrials.gov registry entry for NCT00611078 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00611078 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00611078 about?
NCT00611078 is a clinical study titled "Environmental Pollutants and the Risk of Soft Tissue Sarcoma: A Pilot Study". The purpose of this study is to assess the feasibility of conducting a large hospital based case control study of the role of dioxins and dioxinlike polychlorinated dibenzofurans (PCDFs) and polychlorinated biphenyls (PCBs).
What is the current status of trial NCT00611078?
This trial is currently completed. The enrollment target is 56 participants. The study started on 2004-09. Estimated completion is 2011-01.
Who is sponsoring clinical trial NCT00611078?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.